Literature DB >> 9710229

Human memory T cell differentiation into Th2-like effector cells is dependent on IL-4 and CD28 stimulation and inhibited by TCR ligation.

H Schulze-Koops1, P E Lipsky, L S Davis.   

Abstract

Freshly isolated memory T cells primarily produced IL-2 and small amounts of IL-4 and IFN-gamma after stimulation in vitro. Priming for 5 days in vitro with anti-CD28 monoclonal antibodies (mAb) alone markedly increased production of IL-4. In comparison to fresh cells, the increase in the amount of IL-4 secreted reflected a marked increase in the number of IL-4-producing cells. Stimulation with immobilized anti-CD3 mAb during priming limited subsequent IL-4 production. By contrast, IFN-gamma production from in vitro primed memory T cells was directly correlated to the concentration of priming anti-CD3 mAb. IL-2 production by all restimulated cells was decreased. The differentiation of IL-4-producing cells could be blocked by antibody to IL-4 and enhanced by the addition of recombinant IL-4 as well as antibody to IFN-gamma. Of note, the IL-4-producing effector cells induced from in vitro priming derived from the early CD27pos memory T cell subset, whereas the small CD27neg differentiated memory subset produced IL-4 without in vitro priming. The results indicate that memory T cells can be directed to differentiate into IL-4-producing effector cells by stimulation via CD28 and IL-4, whereas increasing engagement of the TCR limits Th2 memory cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710229     DOI: 10.1002/(SICI)1521-4141(199808)28:08<2517::AID-IMMU2517>3.0.CO;2-5

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  Human CD4+ T cell differentiation and effector function: implications for autoimmunity.

Authors:  L S Davis; H Schulze-Koops; P E Lipsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Lack of Th17 cell generation in patients with severe burn injuries.

Authors:  Akihito Inatsu; Mari Kogiso; Marc G Jeschke; Akira Asai; Makiko Kobayashi; David N Herndon; Fujio Suzuki
Journal:  J Immunol       Date:  2011-08-05       Impact factor: 5.422

3.  Baicalin Alleviates Short-Term Lincomycin-Induced Intestinal and Liver Injury and Inflammation in Infant Mice.

Authors:  Shunfen Zhang; Ruqing Zhong; Shanlong Tang; Hui Han; Liang Chen; Hongfu Zhang
Journal:  Int J Mol Sci       Date:  2022-05-28       Impact factor: 6.208

4.  Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4.

Authors:  S H Kim; C H Evans; S Kim; T Oligino; S C Ghivizzani; P D Robbins
Journal:  Arthritis Res       Date:  2000-05-24

5.  Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells.

Authors:  L S Davis; J J Cush; H Schulze-Koops; P E Lipsky
Journal:  Arthritis Res       Date:  2000-11-02

6.  Anti-human Interleukin(IL)-4 Clone 8D4-8 Cross-Reacts With Myosin-9 Associated With Apoptotic Cells and Should Not Be Used for Flow Cytometry Applications Querying IL-4 Expression.

Authors:  Robert Z Harms; Kiana Borengasser; Vikas Kumar; Nora Sarvetnick
Journal:  Front Cell Dev Biol       Date:  2019-04-09

7.  GATA-3 in human T cell helper type 2 development.

Authors:  Alla Skapenko; Jan Leipe; Uwe Niesner; Koen Devriendt; Rolf Beetz; Andreas Radbruch; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.